Points to Consider From the ESTP Pathology 2.0 Working Group: Overview on Spatial Omics Technologies Supporting Drug Discovery and Development.
Saved in:
| Title: | Points to Consider From the ESTP Pathology 2.0 Working Group: Overview on Spatial Omics Technologies Supporting Drug Discovery and Development. |
|---|---|
| Authors: | Hahn K; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Amberg B; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland., Monné Rodriguez JM; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Verslegers M; Johnson & Johnson, Beerse, Belgium., Kang B; Novartis Biomedical Research, Cambridge, Massachusetts, USA., Wils H; Johnson & Johnson, Beerse, Belgium., Saravanan C; Novartis Biomedical Research, Cambridge, Massachusetts, USA., Bangari DS; Sanofi Global Discovery Pathology, Cambridge, Massachusetts, USA., Long SY; Novartis Biomedical Research, Cambridge, Massachusetts, USA., Youssef SA; Johnson & Johnson, Beerse, Belgium., Pesti B; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Schaffenrath J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Valdeolivas A; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Kumpesa N; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Galván JA; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Richardson M; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Giroud N; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Kunz L; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Veiga IB; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Bscheider M; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Cramer P; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Jiang S; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Kreutzer R; AnaPath Services GmbH, Liestal, Switzerland., Vezzali E; Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland., Yun SW; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Rottenberg S; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.; Bern Center for Precision Medicine and Cancer Therapy Resistance Cluster, Department for BioMedical Research, University of Bern, Bern, Switzerland., Jacobsen B; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland. |
| Source: | Toxicologic pathology [Toxicol Pathol] 2025 Jan; Vol. 53 (1), pp. 107-129. Date of Electronic Publication: 2025 Feb 10. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 7905907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-1601 (Electronic) Linking ISSN: 01926233 NLM ISO Abbreviation: Toxicol Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39930627 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Points to Consider From the ESTP Pathology 2.0 Working Group: Overview on Spatial Omics Technologies Supporting Drug Discovery and Development. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hahn+K%22">Hahn K</searchLink>; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Amberg+B%22">Amberg B</searchLink>; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Monné+Rodriguez+JM%22">Monné Rodriguez JM</searchLink>; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Verslegers+M%22">Verslegers M</searchLink>; Johnson & Johnson, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Kang+B%22">Kang B</searchLink>; Novartis Biomedical Research, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Wils+H%22">Wils H</searchLink>; Johnson & Johnson, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Saravanan+C%22">Saravanan C</searchLink>; Novartis Biomedical Research, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Bangari+DS%22">Bangari DS</searchLink>; Sanofi Global Discovery Pathology, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Long+SY%22">Long SY</searchLink>; Novartis Biomedical Research, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Youssef+SA%22">Youssef SA</searchLink>; Johnson & Johnson, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Pesti+B%22">Pesti B</searchLink>; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schaffenrath+J%22">Schaffenrath J</searchLink>; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Valdeolivas+A%22">Valdeolivas A</searchLink>; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kumpesa+N%22">Kumpesa N</searchLink>; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Galván+JA%22">Galván JA</searchLink>; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Richardson+M%22">Richardson M</searchLink>; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Giroud+N%22">Giroud N</searchLink>; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kunz+L%22">Kunz L</searchLink>; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Veiga+IB%22">Veiga IB</searchLink>; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bscheider+M%22">Bscheider M</searchLink>; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cramer+P%22">Cramer P</searchLink>; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Jiang+S%22">Jiang S</searchLink>; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Kreutzer+R%22">Kreutzer R</searchLink>; AnaPath Services GmbH, Liestal, Switzerland.<br /><searchLink fieldCode="AU" term="%22Vezzali+E%22">Vezzali E</searchLink>; Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.<br /><searchLink fieldCode="AU" term="%22Yun+SW%22">Yun SW</searchLink>; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.<br /><searchLink fieldCode="AU" term="%22Rottenberg+S%22">Rottenberg S</searchLink>; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.; Bern Center for Precision Medicine and Cancer Therapy Resistance Cluster, Department for BioMedical Research, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jacobsen+B%22">Jacobsen B</searchLink>; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227905907%22">Toxicologic pathology</searchLink> [Toxicol Pathol] 2025 Jan; Vol. 53 (1), pp. 107-129. <i>Date of Electronic Publication: </i>2025 Feb 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7905907 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1533-1601 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201926233%22">01926233 </searchLink><i>NLM ISO Abbreviation: </i>Toxicol Pathol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39930627 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/01926233241311258 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 107 Titles: – TitleFull: Points to Consider From the ESTP Pathology 2.0 Working Group: Overview on Spatial Omics Technologies Supporting Drug Discovery and Development. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hahn K – PersonEntity: Name: NameFull: Amberg B – PersonEntity: Name: NameFull: Monné Rodriguez JM – PersonEntity: Name: NameFull: Verslegers M – PersonEntity: Name: NameFull: Kang B – PersonEntity: Name: NameFull: Wils H – PersonEntity: Name: NameFull: Saravanan C – PersonEntity: Name: NameFull: Bangari DS – PersonEntity: Name: NameFull: Long SY – PersonEntity: Name: NameFull: Youssef SA – PersonEntity: Name: NameFull: Pesti B – PersonEntity: Name: NameFull: Schaffenrath J – PersonEntity: Name: NameFull: Valdeolivas A – PersonEntity: Name: NameFull: Kumpesa N – PersonEntity: Name: NameFull: Galván JA – PersonEntity: Name: NameFull: Richardson M – PersonEntity: Name: NameFull: Giroud N – PersonEntity: Name: NameFull: Kunz L – PersonEntity: Name: NameFull: Veiga IB – PersonEntity: Name: NameFull: Bscheider M – PersonEntity: Name: NameFull: Cramer P – PersonEntity: Name: NameFull: Jiang S – PersonEntity: Name: NameFull: Kreutzer R – PersonEntity: Name: NameFull: Vezzali E – PersonEntity: Name: NameFull: Yun SW – PersonEntity: Name: NameFull: Rottenberg S – PersonEntity: Name: NameFull: Jacobsen B IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2025 Jan Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1533-1601 Numbering: – Type: volume Value: 53 – Type: issue Value: 1 Titles: – TitleFull: Toxicologic pathology Type: main |
| ResultId | 1 |
